From Our Desks
Newsletter Winter 2021 - A Note from the CEO, Thomas Seoh
Newsletter Winter 2021 - Founder, Dr. Zan Fleming
Newsletter Winter 2021 - My Adventures with Growth Hormone by Gordon Cutler, M.D.
Newsletter Winter 2021 - Interview with Dr. Nir Barzilai
Newsletter Winter 2021 - GSA Pre-Conference Workshop Q&A
FDA Update - Brian Harvey, MD, Ph.D
Newsletter Fall 2020 - From Kinexum Founder, Zan Fleming
Newsletter Fall 2020 - A Note from the CEO, Thomas Seoh
Newsletter Fall 2020 - Brian Harvey, NASH Development Update—Fall 2020
A New Look for Multiple Therapeutic Shots on Goal for Treating Patients with Metabolic Diseases
Preserving Clinical Trial Integrity in the Midst of a Pandemic — Hint: Don't Shoot the Albatross. by Brian Oscherwitz
Webinar Recap: The Future of Type 1 Diabetes by Brontë Jenkins, Associate, Kinexum
Webinar Recap: Biomarkers of Aging in Regulatory Development by EJ Abass, Associate, Kinexum
Newsletter Summer 2020 - A Note from the CEO, Thomas SeohNewsletter Summer 2020 - From Kinexum Founder, Zan Fleming
Newsletter Summer 2020 - Brian Harvey, NASH Development Update—Summer 2020
Newsletter Summer 2020 - Adriane Berg, Aging at the Tipping Point:
Newsletter Summer 2020 - Shana Azri-Meehan, Preclinical Considerations for the Development of New Antibiotics
Newsletter Summer 2020 - Jennifer Zhao, The Next Generation
Newsletter Spring 2020 From Kinexum Founder, Zan Fleming
Newsletter Spring 2020 Note from CEO, Thomas Seoh
Newsletter Spring 2020 NASH Update—March 2020 by Brian Harvey
Newsletter Spring 2020 Potomac Fever and a Life of Stories by Steven Grossman
Newsletter Spring 2020 THE TARGET PRODUCT PROFILE by Albert Yehaskel
Newsletter Winter 2020 - James Carroll_Why Photobiomodulation Might be the Answer to the Opioid Crisis
Newsletter Winter 2020 note from the CEO
Newsletter Winter 2020 - Thomas Seoh Another Immigrant’s Tale
Newsletter Winter 2020 - Michael Zemel_Reflections on Targeting Metabesity 2019
Newsletter Winter 2020 - Founder, Dr. Zan Fleming
